Patient Care brings primary care clinicians a lot of medical news every day—it’s easy to miss an important study. The Daily Dose provides a concise summary of one of the website's leading stories you may not have seen.
On August 31, 2023, we reported on a study published in the Journal of Investigative Medicine that examined whether COVID-19 vaccination can alter the clinical presentation of post-COVID conditions (PCC).
The study
Researchers analzyed self-reported data provided by patients requesting care for PCC at the Mayo Clinic to assess for an association between vaccination status prior to COVID infection and symptoms of PCC.
The study population included 477 patients who sought treatment for PCC at the Mayo Clinic between May 27, 2021, and July 26, 2022. A total of 245 (51.4%) of participants were vaccinated before COVID-19 infection.
The findings
Vaccinated participants with PCC were half as likely to report experiencing abdominal pain compared with unvaccinated subjects.
Vaccinated participants were less likely to report other symptoms of PCC including anosmia, parosmia, chest pain/tightness, dizziness, numbness/tingling, dyspnea, spells/tremors, and weakness.
When investigators analyzed hospitalized patients with PCC, vaccinated participants reported less chest pain, cough, dizziness, and dyspnea.
Authors' commentary
"We conclude that vaccination against SARS-CoV-2 may reduce the symptoms of PCC, leading to improved morbidity and function. Further studies on the impact of vaccination on PCC and recovery are needed."
The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.